Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/380
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | MOLENBERGHS, Geert | - |
dc.contributor.author | GEYS, Helena | - |
dc.contributor.author | BUYSE, Marc | - |
dc.date.accessioned | 2004-10-25T12:49:42Z | - |
dc.date.available | 2004-10-25T12:49:42Z | - |
dc.date.issued | 2001 | - |
dc.identifier.citation | Statistics in Medicine, 20(20). p. 3023-3038 | - |
dc.identifier.issn | 0277-6715 | - |
dc.identifier.uri | http://hdl.handle.net/1942/380 | - |
dc.description.abstract | A statistical definition of surrogate endpoints as well as validation criteria was first presented by Prentice. Freedman et al. supplemented these criteria with the so-called proportion explained. Buyse and Molenberghs pointed to inadequacies of these criteria and suggested a new definition of surrogacy based on (i) the relative effect linking the overall effect of treatment on both endpoints and (ii) an individual-level measure of agreement between both endpoints. Using data from a randomized trial, they showed how a potential surrogate endpoint can be studied using a joint model for the surrogate and the true endpoint. Whereas Buyse and Molenberghs restricted themselves to the fairly simple cases of jointly normal and jointly binary outcomes, we treat the situation where the surrogate is binary and the true endpoint is continuous, or vice versa. In addition, we consider the case of ordinal endpoints. Further, Buyse et al. extended the approach of Buyse and Molenberghs to a meta-analytic context. We will adopt a similar approach for responses of a mixed data type | - |
dc.description.sponsorship | The authors are grateful to the Pharmacological Therapy for Macular Degeneration Study Group and to F. Hoffman-LaRoche for permission to use their data. | - |
dc.language.iso | en | - |
dc.publisher | JOHN WILEY | - |
dc.rights | (C) 2001 John Wiley & Sons, Ltd. | - |
dc.subject | Clustered data | - |
dc.subject | Clinical trials | - |
dc.subject | Categorical data | - |
dc.title | Evaluation of surrogate endpoints in randomized experiments with mixed discrete and continuous outcomes | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 3038 | - |
dc.identifier.issue | 20 | - |
dc.identifier.spage | 3023 | - |
dc.identifier.volume | 20 | - |
local.bibliographicCitation.jcat | A1 | - |
local.type.refereed | Refereed | - |
local.type.specified | Article | - |
dc.bibliographicCitation.oldjcat | A1 | - |
dc.identifier.doi | 10.1002/sim.923 | - |
dc.identifier.isi | 000171563800003 | - |
item.fulltext | With Fulltext | - |
item.contributor | MOLENBERGHS, Geert | - |
item.contributor | GEYS, Helena | - |
item.contributor | BUYSE, Marc | - |
item.fullcitation | MOLENBERGHS, Geert; GEYS, Helena & BUYSE, Marc (2001) Evaluation of surrogate endpoints in randomized experiments with mixed discrete and continuous outcomes. In: Statistics in Medicine, 20(20). p. 3023-3038. | - |
item.accessRights | Restricted Access | - |
item.validation | ecoom 2002 | - |
crisitem.journal.issn | 0277-6715 | - |
crisitem.journal.eissn | 1097-0258 | - |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
923_ftp.pdf Restricted Access | Published version | 123.84 kB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.